Published in PLoS One on April 27, 2012
Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial (SIT) | NCT00072761
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease | NCT00492531
Sickle Cell Disease Biofluid Chip Technology (SCD BioChip) | NCT02824471
Genetic modifiers of sickle cell disease. Am J Hematol (2012) 1.66
The genetics of complex cholestatic disorders. Gastroenterology (2013) 1.24
Bayesian methods for multivariate modeling of pleiotropic SNP associations and genetic risk prediction. Front Genet (2012) 1.19
Applications of high-throughput DNA sequencing to benign hematology. Blood (2013) 1.01
The search for genetic modifiers of disease severity in the β-hemoglobinopathies. Cold Spring Harb Perspect Med (2012) 0.99
Minireview: Genetic basis of heterogeneity and severity in sickle cell disease. Exp Biol Med (Maywood) (2016) 0.94
Genetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liver. Hum Mol Genet (2014) 0.93
Genetic determinants of haemolysis in sickle cell anaemia. Br J Haematol (2013) 0.89
Genetics of human metabolism: an update. Hum Mol Genet (2015) 0.87
Gene-centric association study of acute chest syndrome and painful crisis in sickle cell disease patients. Blood (2013) 0.86
Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease. Public Health Genomics (2014) 0.84
Genomic approaches to identifying targets for treating β hemoglobinopathies. BMC Med Genomics (2015) 0.83
Minireview: Clinical severity in sickle cell disease: the challenges of definition and prognostication. Exp Biol Med (Maywood) (2016) 0.82
NRMT1 knockout mice exhibit phenotypes associated with impaired DNA repair and premature aging. Mech Ageing Dev (2015) 0.80
Early complication in sickle cell anemia children due to A(TA)nTAA polymorphism at the promoter of UGT1A1 gene. Dis Markers (2013) 0.79
Exome-Wide Association Study Identifies New Low-Frequency and Rare UGT1A1 Coding Variants and UGT1A6 Coding Variants Influencing Serum Bilirubin in Elderly Subjects: A Strobe Compliant Article. Medicine (Baltimore) (2015) 0.79
Combined effects of smoking and bilirubin levels on the risk of lung cancer in Korea: the severance cohort study. PLoS One (2014) 0.79
Emerging point-of-care technologies for sickle cell disease screening and monitoring. Expert Rev Med Devices (2016) 0.75
Comment on "Molecular analysis and association with clinical and laboratory manifestations in children with sickle cell anemia". Rev Bras Hematol Hemoter (2014) 0.75
Do Alpha Thalassemia, Fetal Hemoglobin, and the UGT1A1 Polymorphism have an Influence on Serum Bilirubin Levels and Cholelithiasis in Patients with Sickle Cell Disease? Mol Diagn Ther (2017) 0.75
Multiple Testing in the Context of Gene Discovery in Sickle Cell Disease Using Genome-Wide Association Studies. Genomics Insights (2017) 0.75
Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet (2006) 115.71
MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol (2010) 26.41
Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA (2003) 8.18
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med (2002) 7.59
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med (1995) 6.73
ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics (2010) 6.46
Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev (2006) 4.46
Cholesterol gallstone disease. Lancet (2006) 2.83
Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan. J Clin Oncol (2009) 2.40
UGT1A1*28 allele and coronary heart disease: the Rotterdam Study. Clin Chem (2003) 2.37
Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation (2006) 2.18
Genome-wide association meta-analysis for total serum bilirubin levels. Hum Mol Genet (2009) 1.96
Genome-wide association with select biomarker traits in the Framingham Heart Study. BMC Med Genet (2007) 1.90
Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. Hum Mol Genet (2009) 1.87
The cooperative study of sickle cell disease: review of study design and objectives. Am J Pediatr Hematol Oncol (1982) 1.85
Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain. PLoS One (2008) 1.75
Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity. Blood (2011) 1.64
Laboratory profile of sickle cell disease: a cross-sectional analysis. The Cooperative Study of Sickle Cell Disease. J Clin Epidemiol (1992) 1.61
Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia. Haematologica (2005) 1.58
Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis (2008) 1.47
Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J Biol Chem (1998) 1.45
UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology (2003) 1.42
Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. Gastroenterology (2001) 1.38
Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study. Am J Hematol (2010) 1.34
The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease. Br J Haematol (2007) 1.15
Genome-wide association of serum bilirubin levels in Korean population. Hum Mol Genet (2010) 1.10
Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol (2005) 1.10
Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia. J Pediatr Hematol Oncol (2001) 1.10
Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study. Atherosclerosis (2001) 1.06
Prevalence of clinically relevant UGT1A alleles and haplotypes in African populations. Ann Hum Genet (2011) 1.03
Loci from a genome-wide analysis of bilirubin levels are associated with gallstone risk and composition. Gastroenterology (2010) 1.02
Cholelithiasis and Gilbert's syndrome in homozygous beta-thalassaemia. Br J Haematol (2001) 1.00
Surgical and obstetric outcomes in adults with sickle cell disease. Am J Med (2008) 1.00
Pathogenesis of cholesterol and pigment gallstones: an update. Clin Res Hepatol Gastroenterol (2011) 0.99
A genome scan for loci influencing anti-atherogenic serum bilirubin levels. Eur J Hum Genet (2002) 0.99
Dissecting the genetic heterogeneity of gallbladder stone formation. Semin Liver Dis (2011) 0.97
Association between the UGT1A1 TA-repeat polymorphism and bilirubin concentration in patients with intermittent claudication: results from the CAVASIC study. Clin Chem (2008) 0.94
Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians. Biochem Pharmacol (2003) 0.93
Practical recommendations for the prediction and management of common bile duct stones in patients with gallstones. Surg Endosc (2001) 0.93
UGT1A1 variation and gallstone formation in sickle cell disease. Blood (2004) 0.92
Controversies in bilirubin biochemistry and their clinical relevance. Semin Fetal Neonatal Med (2009) 0.92
Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease. Exp Gerontol (2008) 0.92
UGT1A1 polymorphism outweighs the modest effect of deletional (-3.7 kb) alpha-thalassemia on cholelithogenesis in sickle cell anemia. Am J Hematol (2006) 0.88
Pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 polymorphisms: are we there yet? Pharmacotherapy (2008) 0.88
Inheritance of hyperbilirubinemia: evidence for a major autosomal recessive gene. Dig Liver Dis (2007) 0.85
UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia. Am J Hematol (2008) 0.84
UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia. J Lab Clin Med (2003) 0.84
Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert's syndrome mutations in UGT1A1. Hepatology (2001) 0.83
Hyperbilirubinemia and cholelithiasis in Chinese patients with hemoglobin H disease. Ann Hematol (2005) 0.83
Influence of alpha-thalassemia on cholelithiasis in SS patients with elevated Hb F. Acta Haematol (1998) 0.81
The genetic background of cholesterol gallstone formation: an inventory of human lithogenic genes. Curr Drug Targets Immune Endocr Metabol Disord (2005) 0.80
Early modification of sickle cell disease clinical course by UDP-glucuronosyltransferase 1A1 gene promoter polymorphism. J Hum Genet (2008) 0.78
Combined UGT1A1 and UGT1A7 variant alleles are associated with increased risk of Gilbert's syndrome in Taiwanese adults. Clin Genet (2007) 0.77
[Association between genetic polymorphism of UGT1A7 and susceptibility of bladder cancer]. Zhonghua Yi Xue Za Zhi (2009) 0.77
Risk factors for hyperbilirubinemia and gallstones in Chinese patients with b thalassemia syndrome. Haematologica (2003) 0.77
The effect of UGT1A1 promoter polymorphism on bilirubin response to hydroxyurea therapy in hemoglobinopathies. Clin Biochem (2010) 0.77
Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med (2008) 19.71
A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science (2007) 18.96
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell (2007) 14.58
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol (2009) 12.05
Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54
Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet (2003) 11.01
Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet (2007) 10.78
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet (2007) 9.80
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med (2003) 8.95
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med (2002) 7.59
The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov (2008) 7.58
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet (2011) 7.30
Implementing syndromic surveillance: a practical guide informed by the early experience. J Am Med Inform Assoc (2003) 6.75
The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA (2005) 6.49
Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA (2005) 6.14
Sickle-cell disease. Lancet (2010) 5.64
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58
Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10
Hemoglobin and the paracrine and endocrine functions of nitric oxide. N Engl J Med (2003) 4.98
Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78
Disentangling the roles of disability and morbidity in survival to exceptional old age. Arch Intern Med (2008) 4.77
A genome-wide linkage and association scan reveals novel loci for autism. Nature (2009) 4.76
Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med (2007) 4.63
Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev (2006) 4.46
Retracted Genetic signatures of exceptional longevity in humans. Science (2010) 4.33
Racial disparity in the frequency of recurrence of preterm birth. Am J Obstet Gynecol (2007) 4.30
Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet (2005) 4.21
Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest (2005) 4.14
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet (2009) 4.11
Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet (2009) 4.10
Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet (2010) 3.97
Genomic alterations in cultured human embryonic stem cells. Nat Genet (2005) 3.89
Cluster analysis of gene expression dynamics. Proc Natl Acad Sci U S A (2002) 3.83
Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation (2011) 3.81
Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet (2009) 3.80
Genome-wide association study of PR interval. Nat Genet (2010) 3.73
Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet (2012) 3.71
Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci U S A (2007) 3.58
Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet (2010) 3.55
Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med (2007) 3.29
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med (2014) 3.25
Genetic signatures of exceptional longevity in humans. PLoS One (2012) 3.20
Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J Clin Invest (2005) 3.08
Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature (2004) 2.98
A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet (2002) 2.98
Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res (2007) 2.91
Human embryonic stem cells have a unique epigenetic signature. Genome Res (2006) 2.89
BET bromodomain inhibition as a novel strategy for reactivation of HIV-1. J Leukoc Biol (2012) 2.80
Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet (2010) 2.76
Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. J Am Coll Cardiol (2007) 2.76
Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood (2005) 2.76
Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest (2005) 2.75
Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis. Nat Chem Biol (2006) 2.75
Genomic screen and follow-up analysis for autistic disorder. Am J Med Genet (2002) 2.70
CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70
Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am J Respir Crit Care Med (2007) 2.68
Risk factors for hospital readmission within 30 days: a new quality measure for children with sickle cell disease. Pediatr Blood Cancer (2009) 2.66
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58
Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations. Circulation (2009) 2.55
Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol (2010) 2.55
Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster. Blood (2009) 2.50
Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. JAMA (2005) 2.47
Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation. Circulation (2007) 2.46
Fetal hemoglobin in sickle cell anemia. Blood (2011) 2.44
Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. Hepatology (2013) 2.42
Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood (2006) 2.42
A network model to predict the risk of death in sickle cell disease. Blood (2007) 2.39
Venous thromboembolism: a public health concern. Am J Prev Med (2010) 2.37
The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design. Pediatr Blood Cancer (2010) 2.36
Imputation of missing genotypes: an empirical evaluation of IMPUTE. BMC Genet (2008) 2.34